Clinical Trial Update: Whole Brain Radiation Therapy With Standard Temozolomide Chemo-Radiotherapy and Plerixafor in Treating Patients With Glioblastoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial assessing the addition of plerixafor to standard temozolomide-based chemoradiotherapy for glioblastoma has completed and posted results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma
• Glioblastoma with Primitive Neuronal Component
• Gliosarcoma
• Malignant Glioma
• Oligodendroglioma

Drugs mentioned

• Plerixafor (Plerixafor)
• Temozolomide (Temozolomide)

Snippet

Sponsor: Lawrence D Recht | Conditions: Glioblastoma, Glioblastoma With Primitive Neuronal Component | Phase 2 | Status: COMPLETED | Results posted: 2024-06-26